The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - LOC @ TCPC; supportive care UK
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen Oncology; MSD; Pfizer; Roche; Takeda
Consulting or Advisory Role - Janssen; PharmaMar
Speakers' Bureau - Janssen; Takeda
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); MSD (Inst); PharmaMar (Inst); roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Takeda
Seasonal patterns in immunotherapy outcomes.
 
Oliver Kennedy
No Relationships to Disclose
 
Nadia Ali
No Relationships to Disclose
 
Rebecca Lee
Consulting or Advisory Role - Pierre Fabre
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst)
 
Safwaan Adam
Consulting or Advisory Role - AstraZeneca
Research Funding - Neurocrine Biosciences, Camarus, Crinetics, Debiopharm: all as site Principal Investigator
 
Fiona Helen Blackhall
Honoraria - Amgen; AstraZeneca; AstraZeneca; Bayer; Medivation; Pfizer; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; AstraZeneca; Blueprint Medicines; cell Medica; Janssen; Medivation; Pfizer
Speakers' Bureau - AstraZeneca; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Blueprint Medicines; Boehringer Ingelheim (Inst); Bristol Myers Squibb Foundation (Inst); Celgene; Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Raffaele Califano
No Relationships to Disclose
 
Tim Cooksley
No Relationships to Disclose
 
Laura Cove-Smith
No Relationships to Disclose
 
Victoria Foy
No Relationships to Disclose
 
Avinash Gupta
No Relationships to Disclose
 
Manon Rhys Pillai
No Relationships to Disclose
 
Patricio Serra-Bellver
No Relationships to Disclose
 
Yvonne Summers
No Relationships to Disclose
 
Tom Waddell
Stock and Other Ownership Interests - The Christie Clinic LLP
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer
Consulting or Advisory Role - Eisai Europe; Ipsen; Merck; Merck Sharp & Dohme; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen
 
Paul Lorigan
Stock and Other Ownership Interests - Supportive Care; The Christie Private Care
Honoraria - BMS; Merck; MLA Dx; MSD; NeraCare GmbH; Ultimovacs
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; NeraCare GmbH
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - BMS (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme